Gene · 80310
NIH grants1,097
NIH grants whose papers are about the gene, through NIH's grant-paper links.
261 to 280 of 1,097
Download this page as JSON| Grant | Title | PDGFD papers | Newest fiscal year |
|---|---|---|---|
| I01BX004171 | Downregulation of Rab3D: Critical Role in Golgi Disorganization and the Pathogenesis of Alcoholic Liver Disease | 1 | 2023 |
| K08CA236874 | The Pro-Tumor Immunologic Niche of the Liver | 1 | 2023 |
| KL2TR003143 | Institutional Career Development Core (KL2) | 1 | 2023 |
| P50CA221707 | MD Anderson Cancer Center SPORE in Gastrointestinal Cancer | 1 | 2023 |
| R01AA027242 | The role for alcohol-induced Golgi disorganization in the progression of prostate cancer | 1 | 2023 |
| R01AA027316 | Neural Basis of alcohol/substance use disorders and suicide in American Indians | 1 | 2023 |
| R01AA028711 | Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis | 1 | 2023 |
| R01AI144152 | Role of GDF15 in the Regulation of Host Tolerance to Inflammation | 1 | 2023 |
| R01AI145988 | Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome | 1 | 2023 |
| R01CA099908 | Targeted Therapy for Endometrial Cancer | 1 | 2023 |
| R01CA177909 | Platelets promote growth of ovarian cancer | 1 | 2023 |
| R01CA222393 | Role of SAP30 in hypoxia inducible factor activation and breast cancer progression | 1 | 2023 |
| R01CA240771 | Confocal video-mosaicking microscopy to guide surgery of superficially spreading skin cancers | 1 | 2023 |
| R01DK121132 | Optimization of Novel Small Molecules to Antagonize FGF-23 | 1 | 2023 |
| R01DK123758 | Intestinal single cell analyses and population differences in innate immunity in Crohn's disease drive treatment response and clinical heterogeneity: towards Precision IBD | 1 | 2023 |
| R01DK130362 | Endotheliopathy and liver injury in COVID-19 | 1 | 2023 |
| R01EB028752 | Simultaneous coaxial widefield imaging and reflectance confocal microscopy for improved diagnosis of skin cancers in vivo | 1 | 2023 |
| R01HL046716 | Effect of Cardioplegia and Cardiopulmonary Bypass on Coronary Microvascular Reactivity | 1 | 2023 |
| R01HL103866 | Gut Flora metabolism of dietary carnitine and cardiovascular disease | 1 | 2023 |
| R01HL130845 | Mechanisms regulating VEGF receptors in diabetic angiogenesis | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80310/grants?page=14